Skip to content

Questionnaire survey about COVID-19 clinical practices and physicians' needs for an antiviral

Web-based questionnaire survey of physicians' practices and needs for an antiviral in patients with mild/moderate I COVID-19 without risk factors for disease progression - Questionnaire survey of physicians' practices and needs for antivirals in COVID-19 patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000049688
Enrollment
400
Registered
2022-12-06
Start date
2022-12-13
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Interventions

None listed

Sponsors

SHIONOGI & Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Persons who meet the following criteria in the screening survey -Physician working in internal medicine or respiratory medicine -Persons who have experience in the care of more than 20 mild/moderate I COVID-19 patients without risk factors from July to October 2022

Exclusion criteria

Exclusion criteria: Not applicable

Design outcomes

Primary

MeasureTime frame
Impact on clinical practice when an oral antiviral is approved for mild/moderate I patients without risk factors -Prescription intention of an antiviral and their reasons -Expectation to an antiviral in those patient treatments -Impacts on the burden of health care workers

Secondary

MeasureTime frame
Information on the care of mild/moderate I patients without risk factors -Current practice of treatment, Satisfaction of treatment -Degree of pressure on the medical system: Impact on other medical services, lack of personnel -Burden on healthcare workers and their factors: working hours, infection control measures, and infection risk -Impacts when healthcare workers infected

Countries

Japan

Contacts

Public ContactIppei Morita

SHIONOGI & Co., Ltd. Medical Affairs Department

ippei.morita@shionogi.co.jp070-7812-7168

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026